75
Participants
Start Date
July 29, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
June 30, 2027
KDS2010
KDS2010 will be administered orally once daily, three tablets per day, for 12 weeks. Dosage will be either 120 mg or 180 mg depending on the assigned group.
Placebo
Placebo matching the investigational product in appearance but containing no active ingredient, administered orally once daily, three tablets per day, for 12 weeks.
RECRUITING
The Catholic University of Korea, St. Vincent's Hospital, Suwon
RECRUITING
Kangbuk Samsung Medical Center, Seoul
RECRUITING
Yonsei University Health System, Severance Hospital, Seoul
NeuroBiogen Co., Ltd
INDUSTRY